{"id":5892,"date":"2022-10-25T13:36:40","date_gmt":"2022-10-25T13:36:40","guid":{"rendered":"https:\/\/oncopeptides.com\/about\/valberedning-2023\/"},"modified":"2026-03-06T10:13:18","modified_gmt":"2026-03-06T10:13:18","slug":"valberedning-2023","status":"publish","type":"about-us","link":"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/valberedning-2023\/","title":{"rendered":"Valberedning 2023"},"content":{"rendered":"<p>Enligt principerna f\u00f6r utseende av valberedningen i Oncopeptides AB (publ) ska valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2023 best\u00e5 av ledam\u00f6ter utsedda av de tre r\u00f6stm\u00e4ssigt st\u00f6rsta aktie\u00e4garna per den 30 september som \u00f6nskar delta i valberedningen, tillsammans med styrelsens ordf\u00f6rande.<\/p>\n<p>Valberedningens sammans\u00e4ttning har nu fastst\u00e4llts, och Oncopeptides meddelade idag att valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2023 best\u00e5r av f\u00f6ljande personer som tillsammans representerar cirka 29 procent av antalet aktier och r\u00f6ster i bolaget baserat p\u00e5 aktie\u00e4garinformationen vid utg\u00e5ngen av september.<\/p>\n<ul>\n<li>Staffan Lindstrand, utsedd av HealthCap VI L.P.<\/li>\n<li>Patrik Sobocki, utsedd av Stiftelsen Industrifonden<\/li>\n<li>Caroline Mebius, utsedd av Handelsbanken Fonder<\/li>\n<li>Per Wold-Olsen, styrelsens ordf\u00f6rande<\/li>\n<\/ul>\n","protected":false},"featured_media":0,"parent":5990,"template":"","meta":{"_acf_changed":false},"protected-content":[],"class_list":["post-5892","about-us","type-about-us","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us"}],"about":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/types\/about-us"}],"version-history":[{"count":1,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5892\/revisions"}],"predecessor-version":[{"id":5901,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5892\/revisions\/5901"}],"up":[{"embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5990"}],"wp:attachment":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/media?parent=5892"}],"wp:term":[{"taxonomy":"protected-content","embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/protected-content?post=5892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}